Form D · Biotechnology
SRS Medical Systems, Inc.
North Billerica, MA · CIK 0001495468
Offering snapshot reported Jun 30, 2010 · SEC filing
- Reported sold
- $3.77M Offering amount: $3.77M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2010 | Initial | $3,770,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $210K
- Finders' fees
- $0
- Form D file number
- 021-144253
Broadmark Capital, LLC received warrants in an aggregate exercise amount equal to sales commission paid in this Item 15.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Broadmark Capital, LLC | 118028 |
Source: Form D, filed Jun 30, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee R Brody | Director, Executive |
| Kevin M Connolly | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
76 Treble Cove Road Building #3
North Billerica, MA, 01862
North Billerica, MA, 01862